| Plotted Points Statistics |
| 11-KETOTESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 34 | 92% | 16% | 92% | 15% |
| Total | 34 | 92% | 16% | 92% | 15% |
| Sample Statistics |
| 11-KETOTESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 34 | 89% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 3% | Spiked |
| Spiked | 39 | . | |
| False Negatives | 3 | 8% | 3 out of 38 |
| Not Spiked | 92 | . | |
| False Positives | 0 | 0% | 0 out of 91 |
| Plotted Points Statistics |
| 17-ALPHA-ESTRADIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 72 | 89% | 25% | 88% | 13% |
| Total | 72 | 89% | 25% | 88% | 13% |
| Sample Statistics |
| 17-ALPHA-ESTRADIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 72 | 91% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 4% | Spiked |
| Spiked | 80 | . | |
| False Negatives | 4 | 5% | 4 out of 79 |
| Not Spiked | 51 | . | |
| False Positives | 1 | 2% | 1 out of 50 |
| BQS OBSP Determination: |
| 17-ALPHA-ETHYNYLESTRADIOL |
| METHOD: 4434 , TESTIDCODE: 64529GM005 |
| Open Data Set |
| Plotted Points Statistics |
| 17-ALPHA-ETHYNYLESTRADIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 64 | 81% | 16% | 80% | 13% |
| Total | 64 | 81% | 16% | 80% | 13% |
| Sample Statistics |
| 17-ALPHA-ETHYNYLESTRADIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 64 | 80% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 81 | . | |
| False Negatives | 16 | 20% | 16 out of 80 |
| Not Spiked | 50 | . | |
| False Positives | 2 | 4% | 2 out of 49 |
| Plotted Points Statistics |
| 17-BETA-ESTRADIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 85% | 17% | 83% | 12% |
| Total | 69 | 85% | 17% | 83% | 12% |
| Sample Statistics |
| 17-BETA-ESTRADIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 86% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 1% | Spiked |
| Spiked | 82 | . | |
| False Negatives | 10 | 13% | 10 out of 80 |
| Not Spiked | 49 | . | |
| False Positives | 0 | 0% | 0 out of 49 |
| Plotted Points Statistics |
| 3-BETA-COPROSTANOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 60 | 82% | 27% | 78% | 28% |
| Total | 60 | 82% | 27% | 78% | 28% |
| Sample Statistics |
| 3-BETA-COPROSTANOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 60 | 77% | Spiked |
| Estimated Values | 3 | 4% | Spiked |
| Deleted Values | 3 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 80 | . | |
| False Negatives | 18 | 23% | 18 out of 78 |
| Not Spiked | 51 | . | |
| False Positives | 0 | 0% | 0 out of 50 |
| Plotted Points Statistics |
| 4,4BISPHENOL F |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 19 | 100% | 29% | 88% | 30% |
| Total | 19 | 100% | 29% | 88% | 30% |
| Sample Statistics |
| 4,4BISPHENOL F |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 19 | 100% | Spiked |
| Estimated Values | 19 | 100% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 20 | . | |
| False Negatives | 0 | 0% | 0 out of 19 |
| Not Spiked | 27 | . | |
| False Positives | 0 | 0% | 0 out of 27 |
| Sample Statistics |
| 4,4BISPHENOL S |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 0 | . | Spiked |
| Estimated Values | 0 | . | Spiked |
| Deleted Values | 2 | 100% | Spiked + Not Spiked |
| Spiked, Censored | 0 | . | Spiked |
| Spiked | 0 | . | |
| False Negatives | 0 | . | 0 out of 0 |
| Not Spiked | 2 | . | |
| False Positives | 0 | . | 0 out of 0 |
| Plotted Points Statistics |
| 4-ANDROSTENE-3,17-DIONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 35 | 69% | 19% | 70% | 19% |
| Total | 35 | 69% | 19% | 70% | 19% |
| Sample Statistics |
| 4-ANDROSTENE-3,17-DIONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 35 | 80% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 7% | Spiked |
| Spiked | 46 | . | |
| False Negatives | 6 | 14% | 6 out of 44 |
| Not Spiked | 85 | . | |
| False Positives | 1 | 1% | 1 out of 85 |
| Plotted Points Statistics |
| BISPHENOL A |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 71 | 77% | 21% | 73% | 22% |
| Total | 71 | 77% | 21% | 73% | 22% |
| Sample Statistics |
| BISPHENOL A |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 71 | 99% | Spiked |
| Estimated Values | 36 | 50% | Spiked |
| Deleted Values | 4 | 3% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 75 | . | |
| False Negatives | 1 | 1% | 1 out of 72 |
| Not Spiked | 56 | . | |
| False Positives | 0 | 0% | 0 out of 55 |
| Plotted Points Statistics |
| CHOLESTEROL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 67 | 87% | 21% | 83% | 19% |
| Total | 67 | 87% | 21% | 83% | 19% |
| Sample Statistics |
| CHOLESTEROL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 67 | 87% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 3 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 80 | . | |
| False Negatives | 10 | 13% | 10 out of 77 |
| Not Spiked | 51 | . | |
| False Positives | 2 | 4% | 2 out of 51 |
| Plotted Points Statistics |
| CIS-ANDROSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 72% | . | 72% | 0% |
| >= Reporting Level | 50 | 76% | 17% | 77% | 18% |
| Total | 51 | 76% | 17% | 76% | 18% |
| Sample Statistics |
| CIS-ANDROSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 51 | 78% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 5 | 8% | Spiked |
| Spiked | 65 | . | |
| False Negatives | 9 | 14% | 9 out of 65 |
| Not Spiked | 66 | . | |
| False Positives | 1 | 2% | 1 out of 64 |
| Plotted Points Statistics |
| DIHYDROTESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 40 | 72% | 18% | 73% | 15% |
| Total | 40 | 72% | 18% | 73% | 15% |
| Sample Statistics |
| DIHYDROTESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 40 | 82% | Spiked |
| Estimated Values | 1 | 2% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 2% | Spiked |
| Spiked | 50 | . | |
| False Negatives | 8 | 16% | 8 out of 49 |
| Not Spiked | 81 | . | |
| False Positives | 1 | 1% | 1 out of 80 |
| Plotted Points Statistics |
| EPITESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 65 | 73% | 17% | 72% | 13% |
| Total | 65 | 73% | 17% | 72% | 13% |
| Sample Statistics |
| EPITESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 65 | 96% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 70 | . | |
| False Negatives | 3 | 4% | 3 out of 68 |
| Not Spiked | 61 | . | |
| False Positives | 0 | 0% | 0 out of 61 |
| Plotted Points Statistics |
| EQUILENIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 36 | 91% | 36% | 89% | 42% |
| Total | 36 | 91% | 36% | 89% | 42% |
| Sample Statistics |
| EQUILENIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 36 | 84% | Spiked |
| Estimated Values | 3 | 7% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 43 | . | |
| False Negatives | 7 | 16% | 7 out of 43 |
| Not Spiked | 43 | . | |
| False Positives | 8 | 19% | 8 out of 42 |
| Plotted Points Statistics |
| EQUILIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 5 | 71% | 18% | 64% | 1% |
| >= Reporting Level | 61 | 68% | 18% | 65% | 16% |
| Total | 66 | 69% | 18% | 65% | 14% |
| Sample Statistics |
| EQUILIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 66 | 85% | Spiked |
| Estimated Values | 66 | 85% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 1% | Spiked |
| Spiked | 79 | . | |
| False Negatives | 11 | 14% | 11 out of 78 |
| Not Spiked | 52 | . | |
| False Positives | 0 | 0% | 0 out of 51 |
| Plotted Points Statistics |
| ESTRIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 72 | 82% | 16% | 81% | 15% |
| Total | 72 | 82% | 16% | 81% | 15% |
| Sample Statistics |
| ESTRIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 72 | 92% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 1% | Spiked |
| Spiked | 80 | . | |
| False Negatives | 5 | 6% | 5 out of 78 |
| Not Spiked | 51 | . | |
| False Positives | 0 | 0% | 0 out of 51 |
| Plotted Points Statistics |
| ESTRONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 66 | 75% | 16% | 74% | 11% |
| Total | 66 | 75% | 16% | 74% | 11% |
| Sample Statistics |
| ESTRONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 66 | 80% | Spiked |
| Estimated Values | 5 | 6% | Spiked |
| Deleted Values | 3 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 5 | 6% | Spiked |
| Spiked | 83 | . | |
| False Negatives | 11 | 13% | 11 out of 82 |
| Not Spiked | 48 | . | |
| False Positives | 0 | 0% | 0 out of 46 |
| Plotted Points Statistics |
| MESTRANOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 50 | 49% | 14% | 48% | 12% |
| Total | 50 | 49% | 14% | 48% | 12% |
| Sample Statistics |
| MESTRANOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 50 | 63% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 2 | 3% | Spiked |
| Spiked | 81 | . | |
| False Negatives | 28 | 35% | 28 out of 80 |
| Not Spiked | 50 | . | |
| False Positives | 2 | 4% | 2 out of 49 |
| Plotted Points Statistics |
| NORETHINDRONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 58 | 79% | 18% | 75% | 16% |
| Total | 58 | 79% | 18% | 75% | 16% |
| Sample Statistics |
| NORETHINDRONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 58 | 73% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 4% | Spiked |
| Spiked | 80 | . | |
| False Negatives | 18 | 23% | 18 out of 79 |
| Not Spiked | 51 | . | |
| False Positives | 0 | 0% | 0 out of 50 |
| Plotted Points Statistics |
| PROGESTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 45% | 15% | 42% | 12% |
| Total | 69 | 45% | 15% | 42% | 12% |
| Sample Statistics |
| PROGESTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 87% | Spiked |
| Estimated Values | 69 | 87% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 81 | . | |
| False Negatives | 10 | 13% | 10 out of 79 |
| Not Spiked | 50 | . | |
| False Positives | 0 | 0% | 0 out of 50 |
| Plotted Points Statistics |
| TESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 55 | 77% | 13% | 77% | 10% |
| Total | 55 | 77% | 13% | 77% | 10% |
| Sample Statistics |
| TESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 55 | 89% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 2 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 63 | . | |
| False Negatives | 7 | 11% | 7 out of 62 |
| Not Spiked | 68 | . | |
| False Positives | 3 | 4% | 3 out of 67 |
| BQS OBSP Determination: |
| TRANS-DIETHYLSTILBESTROL |
| METHOD: 4434 , TESTIDCODE: 64536GM005 |
| Open Data Set |